These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24667782)

  • 41. Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
    Belardinilli F; Capalbo C; Buffone A; Petroni M; Colicchia V; Ferraro S; Zani M; Nicolussi A; D'Inzeo S; Coppa A; Screpanti I; Gulino A; Giannini G
    Clin Biochem; 2015 Sep; 48(13-14):908-10. PubMed ID: 25872148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Next-generation diagnostics: gene panel, exome, or whole genome?
    Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
    Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection of pathogenic mutations in Marfan syndrome by targeted next-generation semiconductor sequencing].
    Lu C; Wu W; Xiao J; Meng Y; Zhang S; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Jun; 30(3):301-4. PubMed ID: 23744319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Model Study of In Silico Proficiency Testing for Clinical Next-Generation Sequencing.
    Duncavage EJ; Abel HJ; Merker JD; Bodner JB; Zhao Q; Voelkerding KV; Pfeifer JD
    Arch Pathol Lab Med; 2016 Oct; 140(10):1085-91. PubMed ID: 27388684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.
    Luthra R; Patel KP; Reddy NG; Haghshenas V; Routbort MJ; Harmon MA; Barkoh BA; Kanagal-Shamanna R; Ravandi F; Cortes JE; Kantarjian HM; Medeiros LJ; Singh RR
    Haematologica; 2014 Mar; 99(3):465-73. PubMed ID: 24142997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
    Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
    Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
    Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
    J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Next generation sequencing in hematolymphoid neoplasia.
    Kuo FC
    Semin Hematol; 2019 Jan; 56(1):2-6. PubMed ID: 30573040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fast clinical molecular diagnosis of hyperphenylalaninemia using next-generation sequencing-based on a custom AmpliSeq™ panel and Ion Torrent PGM sequencing.
    Cao YY; Qu YJ; Song F; Zhang T; Bai JL; Jin YW; Wang H
    Mol Genet Metab; 2014 Dec; 113(4):261-6. PubMed ID: 25456745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting.
    Costa JL; Sousa S; Justino A; Kay T; Fernandes S; Cirnes L; Schmitt F; Machado JC
    Hum Mutat; 2013 Apr; 34(4):629-35. PubMed ID: 23315985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of Next-Generation Sequencer for 24-Chromosome Aneuploidy Screening in Human Embryos.
    Sachdeva K; Discutido R; Albuz F; Almekosh R; Peramo B
    Genet Test Mol Biomarkers; 2017 Nov; 21(11):674-680. PubMed ID: 28885040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.
    Vanni I; Coco S; Truini A; Rusmini M; Dal Bello MG; Alama A; Banelli B; Mora M; Rijavec E; Barletta G; Genova C; Biello F; Maggioni C; Grossi F
    Int J Mol Sci; 2015 Dec; 16(12):28765-82. PubMed ID: 26633390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene.
    Balla B; Árvai K; Horváth P; Tobiás B; Takács I; Nagy Z; Dank M; Fekete G; Kósa JP; Lakatos P
    J Mol Neurosci; 2014 Jun; 53(2):204-10. PubMed ID: 24676943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative study of k-spectrum-based error correction methods for next-generation sequencing data analysis.
    Akogwu I; Wang N; Zhang C; Gong P
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):20. PubMed ID: 27461106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. mInDel: a high-throughput and efficient pipeline for genome-wide InDel marker development.
    Lv Y; Liu Y; Zhao H
    BMC Genomics; 2016 Apr; 17():290. PubMed ID: 27079510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays.
    Sims DJ; Harrington RD; Polley EC; Forbes TD; Mehaffey MG; McGregor PM; Camalier CE; Harper KN; Bouk CH; Das B; Conley BA; Doroshow JH; Williams PM; Lih CJ
    J Mol Diagn; 2016 May; 18(3):336-349. PubMed ID: 27105923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.
    Butler KS; Young MY; Li Z; Elespuru RK; Wood SC
    Regul Toxicol Pharmacol; 2016 Feb; 74():178-86. PubMed ID: 26387931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Challenges of bringing next generation sequencing technologies to clinical molecular diagnostic laboratories.
    Wong LJ
    Neurotherapeutics; 2013 Apr; 10(2):262-72. PubMed ID: 23269496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.